Physician
Pediatric Infectious Disease
Dr. Laura A. Guay, MD
|
|
Give Review
Laura Guay practices Pediatric Infectious Disease. She attended George Washington University School of Medicine. George Washington University School of Medicine is ranked 67 in research and 0 in primary care medicine Laura A. Guay is a published physician. She has 76 papers published. The most current publication "Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children."
Publications
- A Multi-Disciplinary Approach to Implementation Science: The NIH-PEPFAR PMTCT Implementation Science Alliance.
- Neutralization of HIV subtypes A and D by breast milk IgG from women with HIV infection in Uganda.
- Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1 Infected Women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa.
- Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation.
- Early Weaning of HIV-Exposed Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV Prevention Trials in Kampala, Uganda.
- Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
- In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
- Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.
- Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.
- Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of a...
- Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.
- Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliS...
- HIV-1 tropism and survival in vertically infected Ugandan infants.
- The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing.
- Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
- HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
- Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
- Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.
- Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
- Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.
- Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.
- Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Preven...
- Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the...
- Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
- Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
- Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).
- Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).
- Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D.
- Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.
- Analysis of HIV diversity using a high-resolution melting assay.
- Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.
- Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (...
- Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Ugand...
- Decreasing HIV transmission through breastfeeding: moving from evidence to practice.
- Evaluating nurses'' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.
- Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised co...
- Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs.
- Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
- Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda.
- Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women.
- Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
- The relationship of maternal and child HIV infection to security of attachment among Ugandan infants.
- [Nurses and death].
- [Health care for the aged and final support in 4 European countries].
- [Poverty, mental health and survival strategies].
- Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants.
- Hepatitis C virus antibody in HIV-1 infected Ugandan mothers.
- Neurodevelopmental outcomes of Ugandan infants with HIV infection: an application of growth curve analysis.
- Dual transmission of subtype A and D HIV type 1 viruses from a Ugandan woman to her infant.
- Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.
- Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants.
- Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection.
- Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
- A new generation of polyurethane vascular prostheses: rara avis or ignis fatuus?
- Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda.
- Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda.
- The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
- HIV-1 ICD p24 antigen detection in ugandan infants: use in early diagnosis of infection and as a marker of disease progression.
- Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
- A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
- Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers.
- Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A.
- Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission.
- Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network...
- From research to implementation: challenges in the prevention of mother to child HIV transmission in the developing world.
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomi...
- Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.
- HIV and infant feeding--an ongoing challenge.
- Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
- Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda.
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up...
- Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
- Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.
- Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
- Analysis of HIV tropism in Ugandan infants.
Schools
George Washington University School of Medicine And Health Sciences
Rainbow Babies Chldns HospCase West Res
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Education
-
Case Western Reserve University - University Hospitals -
George Washington University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Alison C. Tribble, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan V. Lipton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine L. O'Brien, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James C. King Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pranita D. Tamma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas C. Watson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Laurens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Travassos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaya Goswami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preeti Mehrotra, MD
This Doctor is OpenDoctor Recommended.
|